SHOULD WE REDUCE THE DOSE OF BIOLOGICAL THERAPY TO ALL PATIENTS WITH INFLAMMATORY ARTHRITIS ACHIEVING SUSTAINED THERAPEUTIC GOAL?

dc.conference.dateJUN 14-17, 2017
dc.conference.titleAnnual European Congress of Rheumatology
dc.contributor.authorGonzalez-Alvaro, I.
dc.contributor.authorSanchez-Piedra, C.
dc.contributor.authorAlmodovar, R.
dc.contributor.authorBachiller, J.
dc.contributor.authorBalsa, A.
dc.contributor.authorBlasco, A. J.
dc.contributor.authorCaliz, R.
dc.contributor.authorCandelas, G.
dc.contributor.authorFernandez-Carballido, C.
dc.contributor.authorGarcia-Aparicio, A.
dc.contributor.authorGarcia-Magallon, B.
dc.contributor.authorGarcia-Vicuna, R.
dc.contributor.authorGomez-Centeno, A.
dc.contributor.authorOrtiz, A. M.
dc.contributor.authorSanmarti, R.
dc.contributor.authorSanz, J.
dc.contributor.authorTejera, B.
dc.contributor.authorNotario, I.
dc.contributor.authorSoto, M. J.
dc.contributor.authorPlasencia, C.
dc.contributor.authorHernandez, V.
dc.contributor.authorEspinosa, M.
dc.contributor.authorRamos, C.
dc.contributor.authorLazaro, P.
dc.contributor.authoraffiliation[Gonzalez-Alvaro, I.] HU Princesa, Rheumatol, Madrid, Spain
dc.contributor.authoraffiliation[Garcia-Vicuna, R.] HU Princesa, Rheumatol, Madrid, Spain
dc.contributor.authoraffiliation[Ortiz, A. M.] HU Princesa, Rheumatol, Madrid, Spain
dc.contributor.authoraffiliation[Sanchez-Piedra, C.] SER, Res Unit, Madrid, Spain
dc.contributor.authoraffiliation[Almodovar, R.] HU Fdn Alcorcon, Rheumatol, Alcorcon, Spain
dc.contributor.authoraffiliation[Bachiller, J.] HU Ramon & Cajal, Rheumatol, Madrid, Spain
dc.contributor.authoraffiliation[Balsa, A.] HU La Paz, Rheumatol, Madrid, Spain
dc.contributor.authoraffiliation[Plasencia, C.] HU La Paz, Rheumatol, Madrid, Spain
dc.contributor.authoraffiliation[Caliz, R.] HU Virgen de la Nieves, Rheumatol, Granada, Spain
dc.contributor.authoraffiliation[Notario, I.] HU Virgen de la Nieves, Rheumatol, Granada, Spain
dc.contributor.authoraffiliation[Soto, M. J.] HU Virgen de la Nieves, Rheumatol, Granada, Spain
dc.contributor.authoraffiliation[Candelas, G.] Hosp Clin San Carlos, Rheumatol, Madrid, Spain
dc.contributor.authoraffiliation[Fernandez-Carballido, C.] Hosp Gen Univ, Rheumatol, Elda, Spain
dc.contributor.authoraffiliation[Garcia-Aparicio, A.] Hosp Virgen de la Salud, Rheumatol, Toledo, Spain
dc.contributor.authoraffiliation[Garcia-Magallon, B.] Hosp Gral San Jorge, Rheumatol, Huesca, Spain
dc.contributor.authoraffiliation[Gomez-Centeno, A.] HU Parc Tauli, Rheumatol, Sabadell, Spain
dc.contributor.authoraffiliation[Sanmarti, R.] Hosp Clin Barcelona, Rheumatol, Barcelona, Spain
dc.contributor.authoraffiliation[Sanz, J.] HU Puerta de Hierro, Rheumatol, Majadahonda, Spain
dc.contributor.authoraffiliation[Espinosa, M.] HU Puerta de Hierro, Rheumatol, Majadahonda, Spain
dc.contributor.authoraffiliation[Ramos, C.] HU Puerta de Hierro, Rheumatol, Majadahonda, Spain
dc.contributor.authoraffiliation[Tejera, B.] HU Canarias, Rheumatol, Santa Cruz de Tenerife, Spain
dc.contributor.authoraffiliation[Hernandez, V.] HU Canarias, Rheumatol, Santa Cruz de Tenerife, Spain
dc.contributor.funderAbbvie
dc.date.accessioned2025-01-07T14:19:46Z
dc.date.available2025-01-07T14:19:46Z
dc.date.issued2017-06-01
dc.identifier.doi10.1136/annrheumdis-2017-eular.3836
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/76/Suppl_2/452.1.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/26292
dc.identifier.wosID413181401333
dc.issue.number2
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.page.number452-452
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titleSHOULD WE REDUCE THE DOSE OF BIOLOGICAL THERAPY TO ALL PATIENTS WITH INFLAMMATORY ARTHRITIS ACHIEVING SUSTAINED THERAPEUTIC GOAL?
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number76
dc.wostypeMeeting Abstract

Files